Expert Consensus Statement: Management of Pediatric Persistent Obstructive Sleep Apnea After Adenotonsillectomy
Otolaryngology–Head and Neck Surgery · 2023-02 · 168 (2) · 115-130
DOI: 10.1002/ohn.159 ↗Kurz gefasst
Fachartikel in der Zeitschrift Otolaryngology–Head and Neck Surgery, online erschienen am 26.01.2023. Verfasst von Stacey L Ishman und 13 weiteren Autor:innen. Beteiligte Einrichtung: University of Cincinnati College of Medicine, Cincinnati, Ohio, USA. Hauptthemen laut MEDLINE: Sleep Apnea, Obstructive, Tonsillectomy. Die Arbeit wurde bisher 99-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.
Abstract (Originalsprache)
Objective
To develop an expert consensus statement regarding persistent pediatric obstructive sleep apnea (OSA) focused on quality improvement and clarification of controversies. Persistent OSA was defined as OSA after adenotonsillectomy or OSA after tonsillectomy when adenoids are not enlarged.
Methods
An expert panel of clinicians, nominated by stakeholder organizations, used the published consensus statement methodology from the American Academy of Otolaryngology‐Head and Neck Surgery to develop statements for a target population of children aged 2‐18 years. A medical librarian systematically searched the literature used as a basis for the clinical statements. A modified Delphi method was used to distill expert opinion and compose statements that met a standardized definition of consensus. Duplicate statements were combined prior to the final Delphi survey.
Results
After 3 iterative Delphi surveys, 34 statements met the criteria for consensus, while 18 statements did not. The clinical statements were grouped into 7 categories: general, patient assessment, management of patients with obesity, medical management, drug‐induced sleep endoscopy, surgical management, and postoperative care.
Conclusion
The panel reached a consensus for 34 statements related to the assessment, management and postoperative care of children with persistent OSA. These statements can be used to establish care algorithms, improve clinical care, and identify areas that would benefit from future research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
- Walter Reed National Military Medical Center, Bethesda, Maryland, USA.
- Virginia Mason Medical Center, Seattle, Washington, USA.
- University of Rochester Medical Center/Golisano Children's Hospital, Rochester, New York, USA.
- Eastern Virginia Medical School/Children's Hospital of the King's Daughter, Norfolk, Virginia, USA.
- Sainte-Justine Hospital, University of Montreal, Montreal, Quebec, Canada.
Förderung
- NHLBI NIH HHS
Zitieren
APA
Ishman, S. L., Maturo, S., Schwartz, S., McKenna, M., Baldassari, C. M., Bergeron, M., Chernobilsky, B., Ehsan, Z., Gagnon, L., Liu, Y. C., Smith, D. F., Stanley, J., Zalzal, H., & Dhepyasuwan, N. (2023). Expert Consensus Statement: Management of Pediatric Persistent Obstructive Sleep Apnea After Adenotonsillectomy. Otolaryngology–Head and Neck Surgery, 168(2), 115-130. https://doi.org/10.1002/ohn.159
Vancouver
Ishman SL, Maturo S, Schwartz S, McKenna M, Baldassari CM, Bergeron M, et al. Expert Consensus Statement: Management of Pediatric Persistent Obstructive Sleep Apnea After Adenotonsillectomy. Otolaryngology–Head and Neck Surgery. 2023;168(2):115-130. doi:10.1002/ohn.159
BibTeX
@article{Ishman2023,
author = {Ishman, Stacey L and Maturo, Stephen and Schwartz, Seth and McKenna, Margo and Baldassari, Cristina M and Bergeron, Mathieu and Chernobilsky, Boris and Ehsan, Zarmina and Gagnon, Lisa and Liu, Yi-Chun Carol and Smith, David F and Stanley, Jeffrey and Zalzal, Habib and Dhepyasuwan, Nui},
title = {Expert Consensus Statement: Management of Pediatric Persistent Obstructive Sleep Apnea After Adenotonsillectomy},
journal = {Otolaryngology–Head and Neck Surgery},
year = {2023},
volume = {168},
number = {2},
pages = {115--130},
doi = {10.1002/ohn.159}
}
EUVIMED